Literature DB >> 15175521

Community tobacco control leaders' perceptions of harm reduction.

A M Joseph1, D Hennrikus, M J Thoele, R Krueger, D Hatsukami.   

Abstract

OBJECTIVE: To investigate community tobacco control leaders' attitudes toward harm reduction approaches to tobacco use, in order to assess benefits and risks associated with these strategies.
DESIGN: Cross sectional design involving qualitative outcomes from nine structured focus groups.
SUBJECTS: 47 community tobacco control leaders in Minnesota working in the areas of public policy, clinical treatment of nicotine dependence and youth development participated. OUTCOME MEASURES: Participants discussed definitions of harm reduction; benefits and risks of harm reduction methods; and how funds for tobacco control research and programmes should be allocated.
RESULTS: Results indicated inconsistency about the definition of harm reduction: most groups included a broad range of strategies that extended beyond those typically referenced in the scientific literature. Many participants stated that harm reduction might be beneficial, particularly for smokers who could not or would not quit. However, most also expressed concern about a number of risks, including delivering a mixed message about tobacco, inadvertently benefiting the tobacco industry, and causing unanticipated negative health effects. Participants were inclined to suggest public policy measures (for example, smoking bans, increased taxes) as means for reducing harm.
CONCLUSIONS: Results indicate that even among tobacco control leaders there is a need for common terminology to describe harm reduction approaches and that public policy approaches to harm reduction are considered more dependable than strategies that involve pharmaceutical treatment or rely on the tobacco industry, such as product modification.

Entities:  

Mesh:

Year:  2004        PMID: 15175521      PMCID: PMC1747850          DOI: 10.1136/tc.2003.004242

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  9 in total

1.  Two behavioral treatments for smoking reduction: a pilot study.

Authors:  R L Riggs; J R Hughes; J L Pillitteri
Journal:  Nicotine Tob Res       Date:  2001-02       Impact factor: 4.244

Review 2.  Reduced smoking: an introduction and review of the evidence.

Authors:  J R Hughes
Journal:  Addiction       Date:  2000-01       Impact factor: 6.526

3.  Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction.

Authors:  L T Kozlowski; A A Strasser; G A Giovino; P A Erickson; J V Terza
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

4.  Reducing tobacco harm: research challenges and issues.

Authors:  Dorothy K Hatsukami; John Slade; Neal L Benowitz; Gary A Giovino; Ellen R Gritz; Scott Leischow; Kenneth E Warner
Journal:  Nicotine Tob Res       Date:  2002       Impact factor: 4.244

5.  Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?

Authors:  K O Fagerström; R Tejding; A Westin; E Lunell
Journal:  Tob Control       Date:  1997       Impact factor: 7.552

6.  Long-term follow-up (3-4 years) of treatment for smoking reduction.

Authors:  G Colletti; J A Supnick; A A Rizzo
Journal:  Addict Behav       Date:  1982       Impact factor: 3.913

7.  Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.

Authors:  R D Hurt; G A Croghan; T D Wolter; I T Croghan; K P Offord; G M Williams; M V Djordjevic; J P Richie; A M Jeffrey
Journal:  Nicotine Tob Res       Date:  2000-11       Impact factor: 4.244

8.  Tobacco harm reduction: conceptual structure and nomenclature for analysis and research.

Authors:  Saul Shiffman; Joe G Gitchell; Kenneth E Warner; John Slade; Jack E Henningfield; John M Pinney
Journal:  Nicotine Tob Res       Date:  2002       Impact factor: 4.244

9.  Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial.

Authors:  Jean-François Etter; Evelyne Laszlo; Jean-Pierre Zellweger; Charles Perrot; Thomas V Perneger
Journal:  J Clin Psychopharmacol       Date:  2002-10       Impact factor: 3.153

  9 in total
  11 in total

1.  New tobacco products: do smokers like them?

Authors:  R S Caraballo; L L Pederson; N Gupta
Journal:  Tob Control       Date:  2006-02       Impact factor: 7.552

2.  Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products.

Authors:  Lois Biener; Karen Bogen; Gregory Connolly
Journal:  Tob Control       Date:  2007-10       Impact factor: 7.552

Review 3.  Asian herbal-tobacco cigarettes: "not medicine but less harmful"?

Authors:  Aiyin Chen; Stanton Glantz; Elisa Tong
Journal:  Tob Control       Date:  2007-04       Impact factor: 7.552

4.  Snus use and rejection in the USA.

Authors:  Lois Biener; Anthony M Roman; Scott A Mc Inerney; Dragana Bolcic-Jankovic; Dororthy K Hatsukami; Alexandra Loukas; Richard J O'Connor; Laura Romito
Journal:  Tob Control       Date:  2014-02-25       Impact factor: 7.552

Review 5.  Developing the science base for reducing tobacco harm.

Authors:  Dorothy K Hatsukami; Anne M Joseph; Mark Lesage; Joni Jensen; Sharon E Murphy; Paul R Pentel; Michael Kotlyar; Eugene Borgida; Chap Le; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

6.  Characteristics of current and recent former smokers associated with the use of new potential reduced-exposure tobacco products.

Authors:  Mark Parascandola; Erik Augustson; Allison Rose
Journal:  Nicotine Tob Res       Date:  2009-11-13       Impact factor: 4.244

7.  The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.

Authors:  Mitchell Zeller; Dorothy Hatsukami
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552

8.  Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands.

Authors:  Mark Parascandola; Erik Augustson; Mary E O'Connell; Stephen Marcus
Journal:  Nicotine Tob Res       Date:  2009-06-18       Impact factor: 4.244

Review 9.  Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers.

Authors:  Stephen S Hecht; Fekadu Kassie; Dorothy K Hatsukami
Journal:  Nat Rev Cancer       Date:  2009-07       Impact factor: 60.716

10.  Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness.

Authors:  Karen Bogen; Lois Biener; Catherine A Garrett; Jane Allen; K Michael Cummings; Anne Hartman; Stephen Marcus; Ann McNeill; Richard J O'Connor; Mark Parascandola; Linda Pederson
Journal:  Harm Reduct J       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.